Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.77% | $4.67M | €450.67B | 61.10% | 76 Outperform | |
| Roche Holding AG | 2.25% | $2.79M | CHF287.79B | 42.71% | 73 Outperform | |
| Novartis AG | 2.11% | $2.62M | CHF235.62B | 31.22% | 80 Outperform | |
| AstraZeneca | 2.08% | $2.58M | £231.12B | 29.12% | 80 Outperform | |
| HSBC Holdings | 2.03% | $2.51M | £217.54B | 42.42% | 80 Outperform | |
| Nestlé SA | 1.79% | $2.21M | CHF200.67B | 13.36% | 71 Outperform | |
| Shell (UK) | 1.56% | $1.93M | £163.31B | 7.42% | 73 Outperform | |
| Siemens | 1.53% | $1.90M | €200.53B | 11.12% | 74 Outperform | |
| SAP SE | 1.42% | $1.76M | €193.22B | -38.11% | 66 Neutral | |
| Banco Santander | 1.24% | $1.54M | €151.11B | 81.40% | 73 Outperform |